AstraZeneca PLC - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
AstraZeneca PLC (AstraZeneca or 'the company') is a manufacturer, developer, and marketer of prescription pharmaceuticals. The company provides drugs for various therapeutic areas, including oncology, cardiovascular, renal, and metabolic disease (CVRM), respiratory, inflammation and autoimmunity, infection and vaccines, and neuroscience. AstraZeneca markets its products under Accolate, Casodex, Byetta, Diprivan, Faslodex, Zoladex, Tagrisso, Iressa, Symbicort, Pulmicort, Lynparza, Nexium and Onglyza brand names. The company sells its products to specialty care through wholly owned local marketing companies, local representative offices and distributors. It has business presence across the Americas, Africa, Europe, and Asia. The company is headquartered in Cambridge, Cambridgeshire, the UK.Scope
- Detailed information on AstraZeneca PLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting AstraZeneca PLC in the form of a SWOT analysis
- An in-depth view of the business model of AstraZeneca PLC including a breakdown and examination of key business segments
- Intelligence on AstraZeneca PLC's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about AstraZeneca PLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of AstraZeneca PLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess AstraZeneca PLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on AstraZeneca PLC's business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- AstraZeneca PLC: Company Overview
- AstraZeneca PLC: Overview and Key Facts
- AstraZeneca PLC: Overview
- AstraZeneca PLC: Key Facts
- AstraZeneca PLC: Key Employees
- AstraZeneca PLC: Key Employee Biographies
- AstraZeneca PLC: Major Products and Services
- AstraZeneca PLC: Company History
- AstraZeneca PLC: Management Statement
- AstraZeneca PLC: Locations and Subsidiaries
- AstraZeneca PLC: Key Competitors
- AstraZeneca PLC: Company Analysis
- AstraZeneca PLC: Business Description
- AstraZeneca PLC: SWOT Analysis
- AstraZeneca PLC: SWOT Overview
- AstraZeneca PLC: Strengths
- AstraZeneca PLC: Weaknesses
- AstraZeneca PLC: Opportunities
- AstraZeneca PLC: Threats
- AstraZeneca PLC: Corporate Financial Deals Activity
- AstraZeneca PLC: Financial Deals Overview
- AstraZeneca PLC: Targets and Partners
- AstraZeneca PLC: Top Deals 2021 - 2025YTD*
- AstraZeneca PLC: Advisors
- AstraZeneca PLC: Top Legal Advisors
- AstraZeneca PLC: Top Financial Advisors
- AstraZeneca PLC: Mergers and Acquisitions
- AstraZeneca PLC: Corporate Venturing
- AstraZeneca PLC: Capital Raising
- AstraZeneca PLC: Partnership
- AstraZeneca PLC: Divestments
- AstraZeneca PLC: Recent Developments
- AstraZeneca PLC: News and Events Summary
- AstraZeneca PLC: Corporate Governance
- AstraZeneca PLC: Market Developments
- AstraZeneca PLC: Research & Development
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
Table 1: AstraZeneca PLC: Key Facts
Table 2: AstraZeneca PLC: Key Employees
Table 3: AstraZeneca PLC: Company History
Table 4: AstraZeneca PLC: Locations and Subsidiaries
Table 5: AstraZeneca PLC: Key Competitors
Table 6: AstraZeneca PLC: Deal Activity by Deal Type - Volume (TTM*)
Table 7: AstraZeneca PLC: M&A Activity by Geography (TTM*)
Table 8: AstraZeneca PLC: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Table 9: AstraZeneca PLC: M&A Average Deal Size - Value (US$m)
Table 10: AstraZeneca PLC: Targets and Partners
Table 11: AstraZeneca PLC: Top Deals 2021 - 2025YTD*
Table 12: AstraZeneca PLC: Legal Advisor Ranking by Value (US$m)
Table 13: AstraZeneca PLC: Financial Advisor Ranking by Value (US$m)
Table 14: AstraZeneca PLC: M&A Volume and Value Trend (2021 - YTD*2025)
Table 15: AstraZeneca PLC: M&A Activity by Geography (2021 - YTD*2025)
Table 16: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
Table 17: AstraZeneca PLC: Corporate Venturing by Geography (2021 - YTD*2025)
Table 18: AstraZeneca PLC: Capital Raising Volume and Value Trend (2021 - YTD*2025)
Table 19: AstraZeneca PLC: Capital Raising by Deal Type (2021 - YTD*2025)
Table 20: AstraZeneca PLC: Partnership Volume and Value Trend (2021 - YTD*2025)
Table 21: AstraZeneca PLC: Partnership Trend by Deal Type (2021 - YTD*2025)
Table 22: AstraZeneca PLC: Divestments Volume and Value Trend (2021 - YTD*2025)
Table 23: AstraZeneca PLC: Divestments by Geography (2021 - YTD*2025)
Table 24: AstraZeneca PLC: News and Events Summary
Table 25: AstraZeneca PLC: Corporate Governance
Table 26: AstraZeneca PLC: Market Developments
Table 27: AstraZeneca PLC: Research & Development
List of Figures
Figure 1: AstraZeneca PLC: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: AstraZeneca PLC: M&A Activity by Geography (TTM*)
Figure 3: AstraZeneca PLC: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Figure 4: AstraZeneca PLC: M&A Average Deal Size - Value (US$m)
Figure 5: AstraZeneca PLC: M&A Volume and Value Trend (2021 - YTD*2025)
Figure 6: AstraZeneca PLC: M&A Activity by Geography (2021 - YTD*2025)
Figure 7: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
Figure 8: AstraZeneca PLC: Corporate Venturing by Geography (2021 - YTD*2025)
Figure 9: AstraZeneca PLC: Capital Raising Volume and Value Trend (2021 - YTD*2025)
Figure 10: AstraZeneca PLC: Capital Raising by Deal Type (2021 - YTD*2025)
Figure 11: AstraZeneca PLC: Partnership Volume and Value Trend (2021 - YTD*2025)
Figure 12: AstraZeneca PLC: Partnership Trend by Deal Type (2021 - YTD*2025)
Figure 13: AstraZeneca PLC: Divestments Volume and Value Trend (2021 - YTD*2025)
Figure 14: AstraZeneca PLC: Divestments by Geography (2021 - YTD*2025)
